Harrow (HROW) Non-Current Assets (2010 - 2026)
Harrow (HROW) recorded quarterly Non-Current Assets of $193.2 million in Q1 2026, up 2.89% quarter-over-quarter from $187.7 million in Q4 2025, and down 0.76% on a YoY basis from $194.6 million in Q1 2025.
Harrow (HROW) Non-Current Assets (2010 - 2026) Analysis & Trends
Harrow's Non-Current Assets history runs 16 years deep, the most recent figure standing at $193.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 0.76% year-over-year to $193.2 million; the TTM figure through Mar 2026 stood at $756.5 million (down 1.2% YoY), while the FY2025 annual figure was $187.7 million, down 5.81% from the prior year.
- Non-Current Assets was $193.2 million for Q1 2026 at Harrow, up from $187.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $204.5 million in Q3 2024 to a low of $107000.0 in Q4 2022.
- Historically, Non-Current Assets has averaged $109.9 million across 5 years, with a median of $170.1 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets plunged 74.03% in 2022, then jumped 161285.05% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $107000.0 in 2022, then surged by 161285.05% to $172.7 million in 2023, then advanced by 15.43% to $199.3 million in 2024, then fell by 5.81% to $187.7 million in 2025, then increased by 2.89% to $193.2 million in 2026.
- The last three Non-Current Assets figures came in at $193.2 million (Q1 2026), $187.7 million (Q4 2025), and $185.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 193.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.16 Mn |
| Dec 31, 2025 | 187.73 Mn |
| Sep 30, 2025 | 185.47 Mn |
| Jun 30, 2025 | 190.14 Mn |
| Mar 31, 2025 | 194.63 Mn |
| Dec 31, 2024 | 199.32 Mn |
| Sep 30, 2024 | 204.48 Mn |
| Jun 30, 2024 | 167.24 Mn |
| Mar 31, 2024 | 170.08 Mn |
| Dec 31, 2023 | 172.68 Mn |
| Sep 30, 2023 | 780,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 994,000.00 |
| Jun 30, 2022 | 773,000.00 |
| Mar 31, 2022 | 360,000.00 |
| Dec 31, 2021 | 412,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Jun 30, 2021 | 43,000.00 |